Telmisartan activates endothelial nitric oxide synthase via Ser1177 phosphorylation in vascular endothelial cells.
Because endothelial nitric oxide synthase (eNOS) has anti-inflammatory and anti-arteriosclerotic functions, it has been recognized as one of the key molecules essential for the homeostatic control of blood vessels other than relaxation of vascular tone. Here, we examined whether telmisartan modulate...
Main Authors: | Masahiro Myojo, Daisuke Nagata, Daishi Fujita, Arihiro Kiyosue, Masao Takahashi, Hiroshi Satonaka, Yoshiyuki Morishita, Tetsu Akimoto, Ryozo Nagai, Issei Komuro, Yasunobu Hirata |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4020804?pdf=render |
Similar Items
-
Impact of the distance from the stent edge to the residual plaque on edge restenosis following everolimus-eluting stent implantation.
by: Masao Takahashi, et al.
Published: (2015-01-01) -
Nicorandil attenuates monocrotaline-induced vascular endothelial damage and pulmonary arterial hypertension.
by: Makoto Sahara, et al.
Published: (2012-01-01) -
Telmisartan Loaded Nanofibers Enhance Re-Endothelialization and Inhibit Neointimal Hyperplasia
by: Chen-Hung Lee, et al.
Published: (2021-10-01) -
Retraction to 10.1177/1758835920922055
Published: (2023-04-01) -
Role of circulating endothelial progenitors in responsiveness to erythropoiesis-stimulating agents in hemodialysis patients
by: Akira Ishimitsu, et al.
Published: (2021-10-01)